BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31818650)

  • 1. Dosimetry of ruthenium-106 ophthalmic applicators with thin layer thermoluminescence dosimeters - Clinical quality control.
    Krause F; Möller M; Risske F; Siebert FA
    Z Med Phys; 2020 May; 30(2):142-147. PubMed ID: 31818650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dosimetry of ruthenium applicators with an eye phantom and small volume thermoluminescence detectors].
    Muskalla K; Pothmann B; Alberti W; Bornfeld N; Foerster MH; Harder D; Hermann KP; Tabor P; Sack H; Wessing A
    Fortschr Ophthalmol; 1989; 86(6):655-8. PubMed ID: 2625294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy relevant weak sites in industrial quality assurance of 106Ru eye plaques].
    Kaulich TW; Zurheide J; Flühs D; Haug T; Nüsslin F; Bamberg M
    Strahlenther Onkol; 2001 Nov; 177(11):616-23; discussion 624-7. PubMed ID: 11757185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results and implications of high-resolution surface dosimetry of ruthenium-106 eye applicators.
    Menapace R; Binder W; Chiari A
    Ophthalmologica; 1992; 204(2):93-100. PubMed ID: 1594188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determination of dose characteristics of ruthenium ophthalmic applicators using radiochromic film.
    Taccini G; Cavagnetto F; Coscia G; Garelli S; Pilot A
    Med Phys; 1997 Dec; 24(12):2034-7. PubMed ID: 9434987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical quality assurance for 106Ru ophthalmic applicators.
    Kaulich TW; Zurheide J; Haug T; Nüsslin F; Bamberg M
    Radiother Oncol; 2005 Jul; 76(1):86-92. PubMed ID: 15972240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miniature thermoluminescent detectors for dosimetry in radiotherapy.
    Bilski P; Waligórski MP; Budzanowski M; Ochab E; Olko P
    Radiat Prot Dosimetry; 2002; 101(1-4):473-6. PubMed ID: 12382794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dosimetric study of Leipzig applicators.
    Pérez-Calatayud J; Granero D; Ballester F; Puchades V; Casal E; Soriano A; Crispín V
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):579-84. PubMed ID: 15890603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brachytherapy using Ru-106 applicators in ophthalmology].
    Binder W; Menapace R; Seitz W
    Strahlenther Onkol; 1990 Oct; 166(10):639-42. PubMed ID: 2237745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurements regarding a combined therapy concept for ophthalmic tumors consisting of brachytherapy and x-rays.
    Manke H; Fluehs D; Stroth M; Bechrakis NE; Foerster AMH; Albrecht J
    Biomed Phys Eng Express; 2024 Jun; 10(4):. PubMed ID: 38588642
    [No Abstract]   [Full Text] [Related]  

  • 11. The three-dimensional scintillation dosimetry method: test for a 106Ru eye plaque applicator.
    Kirov AS; Piao JZ; Mathur NK; Miller TR; Devic S; Trichter S; Zaider M; Soares CG; LoSasso T
    Phys Med Biol; 2005 Jul; 50(13):3063-81. PubMed ID: 15972981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of surgeon's absorbed dose in iodine 125 and ruthenium 106 ophthalmic plaque surgery.
    Laube T; Flühs D; Kessler C; Bornfeld N
    Ophthalmology; 2000 Feb; 107(2):366-8; discussion 368-9. PubMed ID: 10690840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monte Carlo calculation of the dose distributions of two 106Ru eye applicators.
    Sánchez-Reyes A; Tello JI; Guix B; Salvat F
    Radiother Oncol; 1998 Nov; 49(2):191-6. PubMed ID: 10052886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform.
    Mostafa L; Rachid K; Ahmed SM
    Phys Med; 2016 Aug; 32(8):1007-18. PubMed ID: 27499370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric characterization and output verification for conical brachytherapy surface applicators. Part I. Electronic brachytherapy source.
    Fulkerson RK; Micka JA; DeWerd LA
    Med Phys; 2014 Feb; 41(2):022103. PubMed ID: 24506635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculation of dose distributions for 12 106Ru/106Rh ophthalmic applicator models with the PENELOPE Monte Carlo code.
    Hermida-López M
    Med Phys; 2013 Oct; 40(10):101705. PubMed ID: 24089895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bebig Valencia-type skin applicators: Dosimetric study and implementation of a dosimetric hybrid technique.
    Anagnostopoulos G; Andrássy M; Baltas D
    Brachytherapy; 2017; 16(5):1044-1056. PubMed ID: 28624329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidimensional dosimetry of ¹⁰⁶Ru eye plaques using EBT3 films and its impact on treatment planning.
    Heilemann G; Nesvacil N; Blaickner M; Kostiukhina N; Georg D
    Med Phys; 2015 Oct; 42(10):5798-808. PubMed ID: 26429254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design and the dosimetry of bi-nuclide radioactive ophthalmic applicators.
    Flühs D; Anastassiou G; Wening J; Sauerwein W; Bornfeld N
    Med Phys; 2004 Jun; 31(6):1481-8. PubMed ID: 15259651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry of beta-ray ophthalmic applicators: comparison of different measurement methods.
    Soares CG; Vynckier S; Järvinen H; Cross WG; Sipilä P; Flühs D; Schaeken B; Mourtada FA; Bass GA; Williams TT
    Med Phys; 2001 Jul; 28(7):1373-84. PubMed ID: 11488568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.